Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Herrin IL. The Evolving Role of the Community Pharmacist in the Fight Against Hormone Receptor Positive Breast Cancer


New advances in the treatment of hormone-positive breast cancer have increased the amount of oral medications in its treatment.  This represents a shift in where patients receive their treatment from the oncologist’s office to the pharmacy and home.  Community pharmacists need to be prepared to be an active participant in the care of this patient population.

Date: Nov 21, 2015 09:00 AM - 10:00 AM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Nov 21, 2015 08:55 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict.  The existence of relationships does not necessarily imply bias or lessen the value of the activity.  All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers.  The relevant commercial financial relationships or affiliations must have occured over the past 12 months.

 
Accreditation Council for Pharmacy Education
Southern Illinois University Edwardsville School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  
 
 
 
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity.   Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
 
 
 

 

Requirements for CE Credit

 
To receive CE credit, the participant must complete the entire course (be present for the entire live presentation, read the monograph in its entirety etc.), complete the online pretest and post-test with a score greater than that specified for the course.   The participant must  also complete the online evaluation.
 
 
Continuing pharmacy education credit is reported to CPE Monitor once the post-test & evaluation are successfully completed.  

 

 

Registration closes on Nov 21, 2015 at 08:55 AM

Registration Closed  

Objectives

  • Explain the role of hormonal therapies for the prevention of breast cancer
  • Identify the role of hormonal therapies in the management of hormone-receptor positive breast cancer
  • Summarize emerging evidence regarding the use of hormonal therapies in breast cancer
  • Explain the mechanism of action of cyclin dependent kinases inhibitors and their potential role in the treatment of breast cancer

Speaker(s)/Author(s)

Keith Hecht picture

Keith Hecht, Pharm.D., BCOP
Associate Professor of Pharmacy Practice, SIUE SOP


Brief Bio : Dr. Hecht is a clinical associate professor in the Department of Pharmacy Practice. Before joining SIUE, Dr. Hecht served as an assistant professor of Pharmacy Practice at the University of Southern Nevada College of Pharmacy. Dr. Hecht received his B.S. (2000) and Doctorate of Pharmacy (2001) from St. Louis College of Pharmacy. Subsequently, he completed a pharmacy practice residency and an oncology specialty residency at the University of Kentucky Chandler Medical Center, where he also obtained a certificate for scholarship of teaching and learning. He has been a board-certified oncology pharmacy specialist since 2004. In addition to his faculty appointment at SIUE, Dr. Hecht also provides clinical services in inpatient oncology at St. John’s Mercy Medical Center. Dr. Hecht is interested in various areas of oncology pharmacy practice including supportive care, patient education, and optimizing patient adherence with oncology medications. His research areas of interest include growth factor support, anti-infective use, and regimen optimization in oncology patients.

Activity Number

0480-0000-15-003-L01-P
Date: 11/21/15
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed